Stoke Therapeutics names Ian Smith as permanent CEO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. FDX
2. CBRS
3. QCOM
4. USO
5. KBH
6. HON
7. MU
8. HTZ
9. SPY
10. GOOGL

Go back to Stoke Therapeutics names Ian Smith as permanent CEO
(NASDAQ: STOK) Delayed: 30.38 -0.73 (2.35%)
Previous Close $31.11    52 Week High $ 
Open $31.18    52 Week Low $ 
Day High $31.96    P/E N/A 
Day Low $30.33    EPS $ 
Volume 518,341